Breaking
European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD
🇺🇸 FDA

Anti-Aging

Page 1 • 1 item

Unlock global anti-aging pharma market insights. Discover drug development, clinical trials, regulatory updates, and investment opportunities.

Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion
NewsAnti-aging/Longevity/Cellular RejuvenationApr 23, 2026

Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion

Avaí Bio becomes first company to receive FDA clearance for cellular rejuvenation trial, marking milestone in $120 billion anti-aging market by 2030.

James Chen, PharmD